Mr. Speaker, our government is committed to continuing working with provinces and territories toward the goal of a universal national pharmacare program. To maintain momentum, we will proceed with our plan to provide ongoing funding of $500 million for a program for high-cost drugs for rare diseases.
In the House of Commons on April 20th, 2021. See this statement in context.